Rane A - Search Results

1

Identification of a novel specific CYP2B6 allele in Africans causing impaired metabolism of the HIV drug efavirenz.

Wang J, Sönnerborg A, Rane A, Josephson F, Lundgren S, Ståhle L, Ingelman-Sundberg M. Wang J, et al. Among authors: rane a. Pharmacogenet Genomics. 2006 Mar;16(3):191-8. doi: 10.1097/01.fpc.0000189797.03845.90. Pharmacogenet Genomics. 2006. PMID: 16495778

2

Identification and phenotype characterization of two CYP3A haplotypes causing different enzymatic capacity in fetal livers.

Rodríguez-Antona C, Jande M, Rane A, Ingelman-Sundberg M. Rodríguez-Antona C, et al. Among authors: rane a. Clin Pharmacol Ther. 2005 Apr;77(4):259-70. doi: 10.1016/j.clpt.2004.11.003. Clin Pharmacol Ther. 2005. PMID: 15903124

3

Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction.

Yasar U, Bennet AM, Eliasson E, Lundgren S, Wiman B, De Faire U, Rane A. Yasar U, et al. Among authors: rane a. Pharmacogenetics. 2003 Dec;13(12):715-20. doi: 10.1097/00008571-200312000-00002. Pharmacogenetics. 2003. PMID: 14646690

4

A novel polymorphic cytochrome P450 formed by splicing of CYP3A7 and the pseudogene CYP3AP1.

Rodriguez-Antona C, Axelson M, Otter C, Rane A, Ingelman-Sundberg M. Rodriguez-Antona C, et al. Among authors: rane a. J Biol Chem. 2005 Aug 5;280(31):28324-31. doi: 10.1074/jbc.M502309200. Epub 2005 Jun 2. J Biol Chem. 2005. PMID: 15937338 Free article.

5

Pharmacogenetics of cyclophosphamide in patients with hematological malignancies.

Xie H, Griskevicius L, Ståhle L, Hassan Z, Yasar U, Rane A, Broberg U, Kimby E, Hassan M. Xie H, et al. Among authors: rane a. Eur J Pharm Sci. 2006 Jan;27(1):54-61. doi: 10.1016/j.ejps.2005.08.008. Epub 2005 Sep 23. Eur J Pharm Sci. 2006. PMID: 16183265 Clinical Trial.

6

Institutional profile: Karolinska Institutet.

Eliasson E, Sim SC, Rane A, Ingelman-Sundberg M. Eliasson E, et al. Among authors: rane a. Pharmacogenomics. 2012 Dec;13(16):1887-91. doi: 10.2217/pgs.12.176. Pharmacogenomics. 2012. PMID: 23215881

7

Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation.

Xie HJ, Yasar U, Lundgren S, Griskevicius L, Terelius Y, Hassan M, Rane A. Xie HJ, et al. Among authors: rane a. Pharmacogenomics J. 2003;3(1):53-61. doi: 10.1038/sj.tpj.6500157. Pharmacogenomics J. 2003. PMID: 12629583

8

Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms.

Yasar U, Lundgren S, Eliasson E, Bennet A, Wiman B, de Faire U, Rane A. Yasar U, et al. Among authors: rane a. Biochem Biophys Res Commun. 2002 Nov 22;299(1):25-8. doi: 10.1016/s0006-291x(02)02592-5. Biochem Biophys Res Commun. 2002. PMID: 12435384

9

Several-fold increase in risk of overanticoagulation by CYP2C9 mutations.

Lindh JD, Lundgren S, Holm L, Alfredsson L, Rane A. Lindh JD, et al. Among authors: rane a. Clin Pharmacol Ther. 2005 Nov;78(5):540-50. doi: 10.1016/j.clpt.2005.08.006. Clin Pharmacol Ther. 2005. PMID: 16321620

10

Effect of cyclophosphamide on gene expression of cytochromes p450 and beta-actin in the HL-60 cell line.

Xie HJ, Lundgren S, Broberg U, Finnström N, Rane A, Hassan M. Xie HJ, et al. Among authors: rane a. Eur J Pharmacol. 2002 Aug 9;449(3):197-205. doi: 10.1016/s0014-2999(02)01995-7. Eur J Pharmacol. 2002. PMID: 12167460

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

875 results

Search Page

Filters